MedPath

SCROPHONIX HP

SCROPHONIX HP

Discontinued
DIN Number

02233363

Drug Class

Human

Market Date

May 25, 1998

Company
HC

terra botanica products ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233363
AIG Number0931593001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

BAPTISIA TINCTORIAActive
Strength: 30 X
Monograph: BAPTISIA TINCTORIA
BARIUM CARBONATEActive
Strength: 30 X
Monograph: BARIUM CARBONATE
BROMINEActive
Strength: 30 X
Monograph: BROMINE
CONIUM MACULATUMActive
Strength: 30 X
Monograph: CONIUM MACULATUM
FERROUS IODIDEActive
Strength: 30 X
Monograph: FERROUS IODIDE
OYSTER SHELLSActive
Strength: 30 X
Monograph: OYSTER SHELLS
PHYTOLACCA DECANDRAActive
Strength: 30 X
Monograph: PHYTOLACCA DECANDRA
POISON IVYActive
Strength: 30 X
Monograph: POISON IVY
SILICON DIOXIDEActive
Strength: 30 X
Monograph: SILICON DIOXIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.